Glossary
Health economics glossary
Plain-English definitions of the terms used in health economics, health financing and health technology assessment, with examples and links to related guides and tools.
A
- Actuarial analysis
The use of statistical and financial methods to project a health insurance scheme's future costs, revenue, membership and reserves, and to test whether it can meet its obligations.
Example: An actuarial analysis might show whether current contribution rates can fund a scheme's benefit package over the next five years.
See also: Benefit Package Costing Sprint
- Allocation key
The measure used to divide shared costs between activities or services, such as staff time, floor space, number of visits or share of direct costs.
Example: Using the number of staff in each department as the key to allocate management costs.
See also: Shared costs
- Allocative efficiency
Spending resources on the mix of interventions that produces the most health (or value) for a given budget. It asks whether we are doing the right things, not only doing things well.
Example: Shifting money from a low-value intervention to one that averts more DALYs per dollar improves allocative efficiency.
See also: Cost-effectiveness analysis explained
B
- Benefit package
The list of services, medicines and other health goods that a health insurance scheme or public system commits to provide or pay for, with any conditions such as co-payments or referral rules.
Example: A benefit package might cover outpatient visits, deliveries and essential medicines at primary care, with specialist care on referral.
See also: Benefit Package Costing Sprint · Health financing and insurance
- Budget impact analysis
An estimate of the change in spending for a specific budget holder, usually over one to five years, if a new intervention is adopted. It answers whether an intervention is affordable, not whether it is good value.
Example: A ministry might use a budget impact analysis to plan the first three years of a new vaccination programme.
See also: Budget impact calculator
C
- Capacity to pay
A household's resources after meeting basic subsistence needs, often measured as total consumption minus subsistence (usually food) spending. Used in one approach to catastrophic health expenditure.
Example: Out-of-pocket spending above 40% of capacity to pay is a commonly used threshold for catastrophic spending.
See also: Catastrophic expenditure calculator
- Capital cost
The cost of items that last more than one year, such as equipment, vehicles, buildings and start-up training. In costing studies, capital costs are spread over their useful life rather than counted in the year of purchase.
Example: A laboratory analyser with a ten-year life is annualised, so only its equivalent annual cost is counted each year.
See also: Equivalent annual cost
- Capitation
A provider payment method in which a provider receives a fixed amount per person enrolled with them for a period, regardless of how many services each person uses.
Example: A primary care clinic might receive a fixed amount per registered member per month.
See also: Provider payment methods compared
- Case-based payment
A provider payment method in which a hospital receives a fixed amount per admission, depending on the category (for example the diagnosis-related group) the case falls into.
Example: All uncomplicated appendectomies might be paid the same rate, whatever the length of stay.
See also: Provider payment methods compared
- Catastrophic health expenditure
Out-of-pocket spending on health that is large relative to a household's resources, for example above a set share of total consumption or of the budget left after basic needs.
Example: Under a 10% budget-share threshold, a household spending 12% of its consumption on health has catastrophic spending.
See also: Measuring financial protection · Calculator
- CHEERS 2022
The Consolidated Health Economic Evaluation Reporting Standards 2022: a 28-item checklist for reporting economic evaluations of health interventions so that readers can understand and assess them.
Example: Journals and HTA bodies often ask for a completed CHEERS 2022 checklist with a submission.
See also: Methods and standards
- Community-based health insurance
Voluntary or semi-voluntary health insurance organised at community level, often for people in the informal sector, in which members pay contributions into a local or national pool.
Example: Contributions may be a flat amount per household or vary by household income group.
See also: Health financing and insurance
- Comparator
The alternative against which an intervention is compared in an economic evaluation — usually current practice, another intervention or no intervention.
Example: A new malaria test might be compared with microscopy, which is current practice in the setting.
See also: Cost-effectiveness analysis explained
- Cost per beneficiary
The full cost of a programme divided by the number of unique people who benefited from it. A measure of efficiency often requested by funders.
Example: A programme costing 150,000 that reached 4,000 unique people has a cost per beneficiary of 37.50.
See also: Calculator · Value-for-money guide
- Cost-benefit analysis
An economic evaluation that values both costs and outcomes in money, so that the net benefit (benefits minus costs) or the benefit-cost ratio can be calculated.
Example: A cost-benefit analysis of a water programme might value health gains and time saved in money and compare them with the programme's cost.
- Cost-consequence analysis
An economic evaluation that reports costs alongside a range of separate outcomes, without combining them into a single ratio, leaving the weighing to the decision-maker.
Example: A report might list the cost of a programme next to the cases detected, deaths averted and patient time saved.
- Cost-effectiveness acceptability curve
A graph showing the probability that an intervention is cost-effective at different threshold values, based on probabilistic sensitivity analysis.
Example: The curve might show a 70% probability of being cost-effective at one threshold and 90% at a higher one.
See also: Probabilistic sensitivity analysis
- Cost-effectiveness analysis
An economic evaluation that compares the costs and health effects of alternatives, with effects measured in a single health unit such as cases averted, life years gained, QALYs or DALYs.
Example: Comparing two HIV testing strategies by their cost per new diagnosis is a cost-effectiveness analysis.
See also: Guide · Economic evaluation and HTA
- Cost-effectiveness plane
A graph with the incremental effect on the horizontal axis and the incremental cost on the vertical axis. Where a result falls shows whether an intervention dominates, is dominated or involves a trade-off.
Example: A result in the south-east quadrant is more effective and cheaper, so the intervention dominates.
See also: ICER and plane explorer
- Cost-effectiveness threshold
The maximum amount a decision-maker is willing or able to pay for one unit of health, such as one DALY averted or one QALY gained. How thresholds should be set is debated.
Example: An intervention with an ICER below the threshold is usually considered cost-effective.
See also: Cost-effectiveness analysis explained
- Cost-of-illness study
A study that estimates the total costs a disease imposes on a health system, households or society over a period, without comparing interventions.
Example: A cost-of-illness study might estimate what households spend on care and lose in income because of tuberculosis.
See also: Costing studies
D
- DALY
Disability-adjusted life year: one year of healthy life lost, through early death or through living with illness or disability. Interventions are assessed by the DALYs they avert.
Example: An intervention that prevents early deaths and long-term disability averts DALYs on both counts.
See also: Cost-effectiveness analysis explained
- Decision tree
A simple model that maps the possible pathways and outcomes following a decision, with a probability, cost and outcome attached to each branch. Suited to short-term, one-off events.
Example: A decision tree might compare testing strategies by following patients through positive and negative results to treatment.
See also: Markov model
- Deterministic sensitivity analysis
Changing one or a few model inputs at a time, over plausible ranges, to see how much the result changes. Often shown as a tornado diagram.
Example: Varying the price of a medicine by ±25% shows how sensitive the ICER is to price.
- Difference-in-differences
An impact evaluation method that compares the change in an outcome over time in a group exposed to a programme with the change in a comparison group that was not, to estimate the programme's effect.
Example: Comparing facility deliveries before and after a fee removal in districts with and without the policy.
See also: Impact evaluation
- Discounting
Converting future costs and health effects into present values, reflecting the general preference for benefits sooner and costs later. The discount rate is usually set by national guidelines.
Example: At a 3% discount rate, a cost of 1,000 in five years has a present value of about 863 today.
See also: Present value
- Discrete choice experiment
A survey method in which people choose between alternatives described by several attributes, such as cost, waiting time and quality, to reveal how they value each attribute.
Example: A discrete choice experiment might show how much weight households give to distance versus price when choosing an insurance plan.
See also: Preference studies
- Dominance
An intervention dominates another when it is both more effective and less costly. A dominated intervention is both less effective and more costly and should not be chosen.
Example: A new strategy that saves money and averts more DALYs than current practice dominates it.
See also: Cost-effectiveness plane
- Donor transition
The process by which a country takes over the financing and management of health programmes previously supported by external funders, as that support declines or ends.
Example: Planning for transition includes costing the programmes to be absorbed and identifying domestic funding.
See also: Costing studies
E
- Economic cost
The value of all resources used to deliver a service, including those not paid for in cash, such as donated goods and volunteer time, valued at their opportunity cost.
Example: Donated medicines have no financial cost to a programme but do have an economic cost.
See also: Costing study checklist
- Equivalent annual cost
The annual cost of a capital item spread over its useful life, taking account of the discount rate: the purchase value divided by an annuity factor.
Example: Equipment worth 10,000 with a five-year life and a 3% discount rate has an equivalent annual cost of about 2,184.
See also: Programme costing template
F
- Fee-for-service
A provider payment method in which providers are paid for each individual service they deliver, according to a fee schedule.
Example: A clinic paid separately for each consultation, test and procedure is paid fee-for-service.
See also: Provider payment methods compared
- Financial cost
The actual money paid for the resources used to deliver a service. Budgets and funding requests are usually based on financial costs.
Example: Salaries paid, medicines bought and rent paid are financial costs.
See also: Economic cost
- Financial protection
The extent to which people can use health services without suffering financial hardship. Usually measured by catastrophic and impoverishing out-of-pocket spending.
Example: Removing user fees for deliveries is intended to improve financial protection for pregnant women.
See also: Measuring financial protection
- Fiscal space
The room in a government's budget to increase spending on a priority, such as health, without compromising the sustainability of its finances.
Example: Fiscal space for health can come from economic growth, reprioritisation, new revenue, efficiency gains or external funding.
See also: Health financing and insurance
G
- Global budget
A provider payment method in which a provider receives a fixed total amount for a period to deliver an agreed range of services, with flexibility over how it is spent.
Example: A district hospital might receive an annual global budget based on its expected activity.
See also: Provider payment methods compared
H
- Health technology assessment
A systematic, multidisciplinary process that uses explicit methods to assess the value of a health intervention — its costs, effects and wider implications — to inform decisions about its use.
Example: An HTA might inform whether a medicine is added to an insurer's benefit package.
See also: HTA readiness self-assessment · Economic evaluation and HTA
I
- ICER
Incremental cost-effectiveness ratio: the difference in cost between two alternatives divided by the difference in their health effects — the extra cost per extra unit of health gained.
Example: An extra cost of 50,000 for 25 extra DALYs averted gives an ICER of 2,000 per DALY averted.
See also: ICER explorer
- Impact evaluation
A study that estimates the change in outcomes caused by a programme or policy, by comparing what happened with an estimate of what would have happened without it (the counterfactual).
Example: An impact evaluation might estimate how much a health insurance programme changed service use.
See also: Impact evaluation
- Impoverishing health expenditure
Out-of-pocket health spending that pushes a household below a poverty line: its consumption is above the line before the spending and below it after.
Example: A household just above the poverty line that pays a large hospital bill may be impoverished by it.
See also: Measuring financial protection
- Ingredients approach
A bottom-up costing method that lists every input used to deliver a service, measures the quantity of each and multiplies it by its unit price.
Example: Costing a vaccination session by adding up staff time, vaccines, syringes, cold chain and transport.
See also: Costing study checklist · Programme costing template
M
- Markov model
A model in which a population moves between defined health states over repeated time cycles, with costs and health outcomes attached to each state. Suited to chronic and recurring conditions.
Example: A Markov model of HIV might track people between states defined by treatment status and disease stage.
See also: Data analytics and modelling
- Model validation
Checks that a model is correctly built and produces credible results, including face validity with experts, technical verification of the code and logic, and comparison with other evidence.
Example: Running extreme values through a model to check that results behave as expected is part of verification.
See also: Methods and standards
N
- Net monetary benefit
The incremental health effect multiplied by the threshold, minus the incremental cost. A positive value means an intervention is cost-effective at that threshold.
Example: 25 extra DALYs averted at a threshold of 3,000, minus an extra cost of 50,000, gives a net monetary benefit of 25,000.
See also: ICER explorer
O
- Opportunity cost
The value of the best alternative use of a resource. In health economics, spending on one intervention means the health that could have been gained from spending the same money elsewhere is given up.
Example: A nurse's time spent on one programme is not available for another; its opportunity cost is what that time could have achieved elsewhere.
- Out-of-pocket payment
Money paid directly by households at the time of using health care, net of any reimbursement from insurance or another third party.
Example: Paying for medicines at a pharmacy without insurance cover is an out-of-pocket payment.
See also: Measuring financial protection
P
- Perspective
The point of view from which costs (and sometimes outcomes) are counted in an economic evaluation or costing study, such as the provider, the health system or society.
Example: A societal perspective includes patients' travel costs and lost income; a health system perspective does not.
See also: Costing study checklist
- Prepayment
Paying for health care before it is needed, through taxes, insurance contributions or premiums, rather than at the point of use.
Example: Monthly insurance contributions are a form of prepayment.
See also: Risk pooling
- Present value
The value today of a future cost or benefit, after discounting: the future amount divided by (1 + discount rate) raised to the number of years.
Example: At 3%, 1,000 received in two years has a present value of about 943.
See also: Discounting
- Price year
The year whose prices all costs in an analysis are expressed in. Costs from other years are adjusted for inflation to the price year.
Example: A study reporting costs in 2026 prices adjusts a 2023 salary figure for inflation between 2023 and 2026.
See also: Costing study checklist
- Priority setting
The process of deciding how to allocate limited resources among competing health interventions and programmes, ideally using explicit criteria and evidence.
Example: Using cost-effectiveness, budget impact and equity criteria to decide which services join a benefit package.
See also: HTA readiness self-assessment
- Probabilistic sensitivity analysis
Varying all uncertain model inputs at once, by drawing values repeatedly from probability distributions, to show the overall uncertainty in the result.
Example: Running a model 5,000 times with inputs drawn from their distributions gives a cloud of results on the cost-effectiveness plane.
See also: Cost-effectiveness acceptability curve
- Propensity score matching
An impact evaluation method that pairs people who received a programme with similar people who did not, based on their estimated probability of taking part, to estimate the programme's effect.
Example: Matching insured and uninsured households with similar characteristics to compare their health spending.
See also: Impact evaluation
Q
- QALY
Quality-adjusted life year: a measure combining length and quality of life, where one year in full health equals one QALY and a year in poorer health counts as less. Interventions are assessed by the QALYs they gain.
Example: Two years lived at a quality weight of 0.5 equal one QALY.
See also: Cost-effectiveness analysis explained
R
- Randomised controlled trial
A study in which participants are randomly assigned to receive an intervention or a comparator, so that differences in outcomes can be attributed to the intervention.
Example: Economic evaluations are often carried out alongside randomised trials, using cost data collected during the trial.
See also: Grant Economic Evaluation Package
- Recurrent cost
The cost of resources used up within a year, such as salaries, medicines, supplies, utilities and transport.
Example: Monthly staff salaries and test kits are recurrent costs.
See also: Capital cost
- Reference case
A set of recommended methods and reporting standards for a type of analysis, so that studies are consistent and comparable.
Example: The iDSI reference case guides economic evaluations; the GHCC reference case guides costing studies.
See also: Methods and standards
- Regression discontinuity
An impact evaluation method that compares people just above and just below a cut-off used to decide eligibility for a programme, who are otherwise similar.
Example: Comparing households just below and just above an income cut-off for subsidised insurance.
See also: Impact evaluation
- Risk pooling
Combining the financial risk of ill health across many people, so that the costs of those who fall ill are shared by all contributors.
Example: Insurance contributions from healthy members help pay for the care of members who are sick.
See also: Health financing and insurance
S
- Scenario analysis
Testing how results change under alternative sets of assumptions, such as a different comparator, time horizon or uptake rate.
Example: Running a budget impact model with slow, expected and fast uptake scenarios.
See also: Budget impact calculator
- Strategic purchasing
Aligning the funding and incentives given to providers with the services people are entitled to, using information on provider performance and population health needs.
Example: An insurer that pays providers based on quality and population needs, rather than simply reimbursing claims, is purchasing strategically.
See also: Provider payment methods compared
- System of Health Accounts
An international framework for tracking health spending in a country: who pays, through which financing schemes, for which services and providers.
Example: Health accounts show how much of total health spending comes from government, insurance, households and external sources.
See also: Health financing and insurance
T
- Tariff
The price a purchaser, such as an insurer, pays a provider for a service or case. Tariffs may be set from costing studies, historical spending or negotiation.
Example: An insurer's tariff for a normal delivery at a health centre.
See also: Costing studies
- Time horizon
The period over which costs and outcomes are counted in an economic evaluation. It should be long enough to capture the important differences between alternatives.
Example: A vaccine that prevents lifelong disability needs a lifetime horizon.
- Top-down costing
A costing method that starts with total expenditure, such as a facility's accounts, and allocates it to services using allocation keys.
Example: Allocating a hospital's total costs to departments by staff numbers, then to patients by bed-days.
See also: Ingredients approach
U
- Unit cost
The cost of producing one unit of output, such as one outpatient visit, one test or one patient treated.
Example: Total annual cost of a clinic's outpatient service divided by the number of visits.
See also: Rapid Costing Study
- Universal health coverage
All people having access to the quality health services they need without suffering financial hardship.
Example: Progress is tracked with indicators of service coverage and financial protection.
See also: Measuring financial protection
- Utility (health state)
A number, usually between 0 (dead) and 1 (full health), that represents how people value a particular health state. Used to calculate QALYs.
Example: A health state with a utility of 0.7 counts as 0.7 of a year in full health for each year lived in it.
See also: QALY
V
- Value for money
The best use of resources to achieve intended results, often assessed through economy, efficiency, effectiveness and equity (the 4Es).
Example: A value-for-money assessment asks whether inputs were bought well, turned into outputs efficiently, achieved outcomes and reached the right people.
See also: Value-for-money guide · VfM analysis for NGOs
W
- Willingness to pay
The maximum amount a person, or a decision-maker, would pay for a good, service or health gain. Measured in surveys and stated-preference studies, or used as a threshold.
Example: A willingness-to-pay study might ask how much households would contribute for an insurance plan.
See also: Preference studies
Need this done properly?
Definitions are the start. When you need the analysis itself, we can scope it with you.
A form of health financing in which contributions, usually linked to income and often mandatory, are pooled in a fund that pays for a defined benefit package for members.
Example: Payroll-based contributions from employers and employees paid into a national health insurance fund.
See also: Health financing and insurance